Abiopharma

CRESCENT CAPITAL BDC, INC. (CCAP)

Symbol	CCAP
Name	CRESCENT CAPITAL BDC, INC.
Sector	FINANCE
Region	North America
Industry	Finance: Consumer Services
Address	11100 SANTA MONICA BOULEVARD,SUITE 2000, LOS ANGELES, California, 90025, United States
Telephone	+1 310 235-5900
Fax	—
Email	—
Website	https://www.crescentbdc.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	—
Description	Crescent Capital BDC, Inc. is a specialty finance company focused on lending to middle-market companies. The Companys investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It invests primarily in secured debt, including first lien, unitranche first lien and second-lien debt, and unsecured debt, including mezzanine and subordinated debt, as well as related equity securities of private United States middle-market companies. It is focused on purchasing interests in loans or make debt investments, either directly from its target companies as primary market or private credit investments (private credit transactions), or primary or secondary market bank loan or high yield transactions in the syndicated market (syndicated loans and bonds). Although its focus is to invest in less liquid private credit transactions. Additional info from NASDAQ: Crescent Capital BDC, Inc. is a specialty finance company focused on lending to middle-market companies. The Companys investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It invests primarily in secured debt, including first lien, unitranche first lien and second-lien debt, and unsecured debt, including mezzanine and subordinated debt, as well as related equity securities of private United States middle-market companies. It is focused on purchasing interests in loans or make debt investments, either directly from its target companies as primary market or private credit investments (private credit transactions), or primary or secondary market bank loan or high yield transactions in the syndicated market (syndicated loans and bonds). Although its focus is to invest in less liquid private credit transactions.

2026-04-27 20:05

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2026 Financial Results

2026-04-01 17:17

New Form DEFA14A - Crescent Capital BDC, Inc. Filed: 2026-04-01 AccNo: 0001140361-26-012760 Size: 1 MB

2026-04-01 17:16

New Form DEF 14A - Crescent Capital BDC, Inc. Filed: 2026-04-01 AccNo: 0001140361-26-012755 Size: 4 MB

2024-07-18 20:05

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Second Quarter Ended June 30, 2024 Financial Results

2024-06-04 10:30

Crescent Capital BDC, Inc. to Host Analyst & Investor Day on June 11, 2024

2024-05-08 20:10

Crescent Capital BDC, Inc. Reports First Quarter Net Investment Income Per Share of $0.63 and NAV Per Share of $20.28; Increases Quarterly Dividend

2024-04-18 20:05

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2024 Financial Results

2024-02-21 21:15

Crescent Capital BDC, Inc. Reports December 31, 2023 Financial Results; Declares a First Quarter Regular Dividend of $0.41 Per Share and Fourth Quarter Supplemental Dividend of $0.10 Per Share

2024-01-23 21:15

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2023 Financial Results

2023-11-08 21:15

Crescent Capital BDC, Inc. Reports September 30, 2023 Financial Results; Declares a Fourth Quarter Regular Dividend of $0.41 Per Share and Third Quarter Supplemental Dividend of $0.09 Per Share